Researchers discover new therapeutic approach for cardiorenal syndrome type 2
A study suggests a new therapeutic approach to treat the development of chronic kidney disease secondary to chronic heart failure, known as cardiorenal syndrome type 2. Researchers suggest inhibiting G protein-coupled receptors (GPCR) could prevent renal damage in cardiorenal syndrome type 2 (CRS2), and could also prevent acute kidney injury (AKI).
Source: ScienceDaily Headlines - Category: Science Source Type: news
More News: Cardiology | Chronic Kidney Disease | Heart | Heart Failure | Science | Study | Urology & Nephrology